Oncolix, Inc.
HOUSTON, TX · CIK 0001574061 · Biotech · Defunct
AI and machine learning platform for accelerating drug discovery in oncology, CNS, and autoimmune disease
oncolix.ai →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $8.9M
- 6 Form D · Feb 2017
- 116 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201220132014201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 3 same day | Form D · SEC | $2,400,000 | |
| Private capital raised· 2 of 3 same day | Form D · SEC | $1,500,000 | |
| Private capital raised· 3 of 3 same day | Form D · SEC | $50,000 | |
| Private capital raised | Form D · SEC | $4,508,704 | |
| Private capital raised | Form D · SEC | $150,000 | |
| Private capital raised | Form D · SEC | $250,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1869 | Kiniksa Pharmaceuticals | — | $5.9M |
| 1870 | Jennerex, Inc. | — | $5.4M |
| 1871 | AKTTYVA THERAPEUTICS, INC. | — | — |
| 1872 | Oncolix, Inc. | — | $8.9M |
| 1873 | COURAGE THERAPEUTICS INC | — | $4.5M |
| 1874 | Factor Holdings LLC | — | $25K |
| 1875 | TearSolutions, Inc. | — | $36M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- J PayneExecutive Officer
- J Donald PayneExecutive Officer
- Joseph PodolskiDirector
- Michael RedmanDirector · Executive Officer
- Jerry YoukeyDirector
- Dale ZajicekDirector
Patents
- Method For Treating Cancers Expressing Prolactin Receptorapplication
- Method For Treating Cancers Expressing Prolactin Receptorapplication
- Compositions And Methods For Visualizing And Eliminating Cancer Stem Cellsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.